BIOMAT Database Logo BIOMAT Database Logo

The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors. 2000

T Nishizaki, and T Nomura, and T Matuoka, and T Kondoh, and G Enikolopov, and G Enikolopo, and K Sumikawa, and S Watabe, and T Shiotani, and M Yoshii
Department of Physiology, Kobe University School of Medicine, Japan. tomo@med.kobe-u.ac.jp

Nefiracetam, a pyrrolidone derivative developed as an anti-dementia drug, persistently potentiated currents through neuronal nicotinic acetylcholine (ACh) receptors (alpha7, alpha4beta2) expressed in Xenopus oocytes, and the potentiation was blocked by either the selective protein kinase C (PKC) inhibitors, GF109203X and staurosporine, or co-expressed active PKC inhibitor peptide. In primary cultures of rat hippocampal neurons, nefiracetam increased the rate of nicotine-sensitive miniature excitatory postsynaptic currents, without affecting the amplitude, and the increase was inhibited by GF109203X. In addition, the drug caused a marked increase in the glutamate release from electrically stimulated guinea pig hippocampal slices, and the effect was abolished by the nicotinic ACh receptor antagonists, alpha-bungarotoxin and mecamylamine. Nefiracetam induced a long-lasting facilitation of synaptic transmission in both the CA1 area and the dentate gyrus of rat hippocampal slices, and the facilitation was inhibited by alpha-bungarotoxin and mecamylamine. Such facilitatory action was still found in the hippocampus with selective cholinergic denervation. The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008301 Maleimides Derivatives of maleimide (the structural formula H2C2(CO)2NH) containing a pyrroledione ring where the hydrogen atom of the NH group is replaced with aliphatic or aromatic groups.
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002491 Central Nervous System Agents A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252) Central Nervous System Drugs
D003714 Denervation The resection or removal of the nerve to an organ or part. Laser Neurectomy,Neurectomy,Peripheral Neurectomy,Radiofrequency Neurotomy,Denervations,Laser Neurectomies,Neurectomies,Neurectomies, Laser,Neurectomies, Peripheral,Neurectomy, Laser,Neurectomy, Peripheral,Neurotomies, Radiofrequency,Neurotomy, Radiofrequency,Peripheral Neurectomies,Radiofrequency Neurotomies
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme

Related Publications

T Nishizaki, and T Nomura, and T Matuoka, and T Kondoh, and G Enikolopov, and G Enikolopo, and K Sumikawa, and S Watabe, and T Shiotani, and M Yoshii
Presynaptic nicotinic ACh receptors.
February 1997, Trends in neurosciences,
T Nishizaki, and T Nomura, and T Matuoka, and T Kondoh, and G Enikolopov, and G Enikolopo, and K Sumikawa, and S Watabe, and T Shiotani, and M Yoshii
Presynaptic alpha-7 nicotinic acetylcholine receptors modulate excitatory synaptic transmission in hippocampal neurons.
December 2003, Sheng li xue bao : [Acta physiologica Sinica],
T Nishizaki, and T Nomura, and T Matuoka, and T Kondoh, and G Enikolopov, and G Enikolopo, and K Sumikawa, and S Watabe, and T Shiotani, and M Yoshii
Inhibitory synaptic transmission in area postrema neurons of the rat showing robust presynaptic facilitation mediated by nicotinic ACh receptors.
January 2007, Brain research,
T Nishizaki, and T Nomura, and T Matuoka, and T Kondoh, and G Enikolopov, and G Enikolopo, and K Sumikawa, and S Watabe, and T Shiotani, and M Yoshii
Presynaptic modulation of ganglionic ACh release by muscarinic and nicotinic receptors.
August 1990, The American journal of physiology,
T Nishizaki, and T Nomura, and T Matuoka, and T Kondoh, and G Enikolopov, and G Enikolopo, and K Sumikawa, and S Watabe, and T Shiotani, and M Yoshii
Nicotinic ACh receptors in the hippocampal circuit; functional expression and role in synaptic plasticity.
October 2014, The Journal of physiology,
T Nishizaki, and T Nomura, and T Matuoka, and T Kondoh, and G Enikolopov, and G Enikolopo, and K Sumikawa, and S Watabe, and T Shiotani, and M Yoshii
The linoleic acid derivative FR236924 facilitates hippocampal synaptic transmission by enhancing activity of presynaptic alpha7 acetylcholine receptors on the glutamatergic terminals.
January 2005, Neuroscience,
T Nishizaki, and T Nomura, and T Matuoka, and T Kondoh, and G Enikolopov, and G Enikolopo, and K Sumikawa, and S Watabe, and T Shiotani, and M Yoshii
Presynaptic nicotinic receptors facilitate monoaminergic transmission.
March 1998, The Journal of neuroscience : the official journal of the Society for Neuroscience,
T Nishizaki, and T Nomura, and T Matuoka, and T Kondoh, and G Enikolopov, and G Enikolopo, and K Sumikawa, and S Watabe, and T Shiotani, and M Yoshii
Presynaptic nicotinic acetylcholine receptors enhance GABAergic synaptic transmission in rat periaqueductal gray neurons.
August 2010, European journal of pharmacology,
T Nishizaki, and T Nomura, and T Matuoka, and T Kondoh, and G Enikolopov, and G Enikolopo, and K Sumikawa, and S Watabe, and T Shiotani, and M Yoshii
Astrocyte activation of presynaptic metabotropic glutamate receptors modulates hippocampal inhibitory synaptic transmission.
November 2004, Neuron glia biology,
T Nishizaki, and T Nomura, and T Matuoka, and T Kondoh, and G Enikolopov, and G Enikolopo, and K Sumikawa, and S Watabe, and T Shiotani, and M Yoshii
Synaptic activation of a presynaptic kainate receptor facilitates AMPA receptor-mediated synaptic transmission at hippocampal mossy fibre synapses.
December 2001, Neuropharmacology,
Copied contents to your clipboard!